Kim Stewart 
Recent research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face ofRead
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders. Study using electronicRead
Deficiency in omega-3 polyunsaturated fatty acids (n-3 PUFAs) has recently been investigated as a potential pathogenetic mechanism in ADHD ((Stevens et al, 1995). Although current pharmacotherapies, such as methylphenidate and atomoxetine, are able to improve ADHD symptoms, there is still about 20-40% of patients with ADHD who do not benefitRead
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an experimental mouse study in the Journal of Alzheimer’s Disease shows that a two-week course of CBD may reduce plaque and improve cognition. Researchers tested aRead
Age and gender matter when it comes to the early COVID-19 symptoms, according to new research from Lancet Digital Health. The differences are most notable between younger age groups (16-to-59 years) compared to older age groups (60-to-80 years and older). Also, men have different symptoms compared to women in theRead
People infected with COVID-19 experience a wide range of symptoms and severity, including high fevers and respiratory problems. However, new research shows that when the virus attacks the gastrointestinal tract, it may increase the severity of the viral infection. The research review, published in mBio, suggests that gut dysfunction andRead
University of Arizona researchers found what may be the key molecular mechanism responsible for COVID-19 mortality, it is the phospholipase A2 group IIA, or sPLA2-IIA enzyme. The sPLA2-IIA enzyme is known to be responsible for severe inflammation, researchers now believe it could be a key mechanism driving COVID-19 severity andRead
Background: Inflammation is a normal and necessary prerequisite to healing of the injured tissues. Inflammation contributes to all disease process including immunity, vascular pathology, trauma, sepsis, chemical, and metabolic injuries. The secretory phospholipase A2 (sPLA2) is a key enzyme in the production of pro-inflammatory mediators in chronic inflammatory disorders suchRead
ABSTRACT/ Andrographis paniculata Nees is an important medicinal plant found in the tropical regions of the world, which has been traditionally used in Indian and Chinese medicinal systems. It is also used as medicinal food. A. paniculata is found to exhibit anti-inflammatory activities; however, its inhibitory potential on inflammatory GroupRead
The findings, from researchers at Imperial College London and University of South Carolina, add to mounting evidence that inflammation, and the accompanying release of the molecule histamine, affects a key molecule responsible for mood in the brain — serotonin. If replicated in humans, the findings — which identify histamine asRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
